BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 16, 2014
View Archived Issues
Kolltan Pharmaceuticals acquires Xetrios Therapeutics
Read More
Liquidia forms oral health company Lq3 Pharmaceuticals
Read More
Asterias Biotherapeutics partners with Cancer Research UK on AST-VAC2 study
Read More
Genocea's universal pneumococcal vaccine enters phase II development
Read More
First-in-human results for MOR-103 in patients with MS
Read More
Meiji Seika Pharma presents preclinical data on OP-0595
Read More
SolaranRx and STC.UNM sign option agreement for melanoma-targeting technology
Read More
Nymox reports 8-month trial data for NX-1207
Read More
Lilly reports phase III RAISE trial meets primary endpoint of overall survival
Read More
Fragment-based drug discovery at Takeda identifies selective LMW BTK inhibitors
Read More
G1 Therapeutics' CDK inhibitor G1T28-1 enters phase I
Read More
Ultragenyx presents promising interim phase I/II results for rhGUS enzyme replacement therapy
Read More
Almirall presents novel inhaled compounds with the ability to reduce airway inflammation
Read More
A novel p62-ZZ domain blocker in animal models of multiple myeloma-associated bone disease
Read More
Eisai patents FGFR inhibitors
Read More
Ono Pharmaceutical identifies Trk-A inhibitors
Read More
Astellas Pharma and Kyoto University present anti-human CD3 epsilon MAb
Read More
FDA approves Rixubis for children with hemophilia B
Read More
FDA accepts filing of supplemental NDA for Vyvanse
Read More
Avanir reports phase II results for AVP-923 for agitation in Alzheimer's disease
Read More
Preclinical data on vesicular stomatitis virus-based Ebola vaccine published
Read More
Prosonix creates drug-only fixed-dose combinations for inhalation
Read More
Roche begins phase III trials of lampalizumab for geographic atrophy
Read More
FDA grants orphan drug designation to Lynovex for cystic fibrosis
Read More
AstraZeneca and Lilly to jointly develop and commercialize BACE inhibitor
Read More
FDA grants tentative approval to Salix's budesonide rectal foam for distal ulcerative colitis
Read More
VolitionRx reports topline results from colorectal screening study with NuQ test
Read More